focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q&A-Pound plunges, stocks up, economy flat: What do Brexit swings mean for you?

Fri, 07th Oct 2016 08:35

By Guy Faulconbridge, Jamie McGeever and David Milliken

LONDON, Oct 7 (Reuters) - Sterling has tumbled to a 31-yearlow, but British stocks are near a record high and, contrary tomany expert forecasts, the shock of Brexit has not yet pushedthe British economy off a cliff.

So what gives?

Depending on which part of the financial universe you lookat, the outlook for UK Plc following the June 23 vote to leavethe European Union can appear equally bright or bleak.

Sterling's plunge makes Britain's exports more competitiveon global markets and is therefore a boost for economic growth.But if sustained, it will fuel inflation and become a source ofworry at the Bank of England.

How does the rest of the world measure Britain's standing asit prepares to divorce from the EU? Which is more telling: thesteep decline in the currency's value, or the recovery in thestock markets and competitiveness?

Below is a guide to what has happened across UK markets andthe economy since the Brexit vote, what lies ahead and what itmeans for Britain.

For full coverage click on the Brexit page: http://emea1.apps.cp.extranet.thomsonreuters.biz/cms/?pageId=brexit&navid=15301

For a weekly round-up of Brexit news: http://share.thomsonreuters.com/assets/newsletters/Specialpackages/Brexit_October5.pdf

WHAT HAS THE IMPACT BEEN SO FAR?

- CURRENCY: Sterling, which traded as high as $1.50on June 23, was last fetching $1.2440.

In early Asian trade on Friday, sterling plunged about 10percent at one point to $1.1378 from around $1.2600, though theoutlying trade was later cancelled and the low was revised to$1.1491 - still, the weakest level for sterling since 1985.

Sterling hit a five-year low against the euro and its loweston a trade-weighted basis since January 2009, in the depths ofthe Great Financial Crisis. It is within a couple of percent offalling to its lowest since at least the 1970s on atrade-weighted basis.

Currency traders have shunned the pound on fears Britaincould be heading towards a so called "hard Brexit" that willinvolve a turbulent negotiation with the other 27 members of theEU resulting in Britain losing its preferential access to theEU's single market while imposing immigration controls.

- SHARES: Britain's FTSE 100 index was up 0.4percent at 7,030.30 points by 0712 GMT, less than 100 pointsaway from its life-time high set in April last year. The indexis up nearly 2 percent so far this week after falling in theprevious week

The blue-chip index has risen 10 percent since itspre-Brexit level - and more than 15 percent from its post-Brexitlow - and has come within a whisker of its historic high of7,122.74.

The FTSE 250, which measures the value of smallerand more domestic-focused firms, hit a record high of 18,607points this week and is up more than 20 percent from thepost-Brexit low of June 27.

The rally in stocks has been fuelled by the BoE's policyresponse and the slump in sterling. A weaker exchange rateboosts the earnings of companies with global operations, andaround 75 percent of FTSE 100 firms' earnings are derived fromabroad.

By contrast, in dollar terms - which is how non-UK investorsmeasure their results - the FTSE 100 is still 8 percent lowerthan it was the day of the referendum and the FTSE 250 is down12 percent.

- BONDS: The 10-year gilt yield touched 0.954percent on Friday, its highest level since June 30 and laststood at 0.949 percent. It was 1.40 percent the day of theBrexit referendum.

But investors are now selling long-dated British governmentdebt, worried by a rise in inflation that is expected to followthe fall in the value of the pound.

- MONETARY POLICY: The Bank of England cut rates on Aug. 4 to the lowest in its 322-year history and unleashed billions ofpounds worth of extra stimulus.

PM May took the unusual step of commenting on central bankpolicy on Wednesday when she said near-zero rates and the BoE'shuge bond-buying programme had hurt savers.

WHAT LIES AHEAD?

STERLING

BoE Deputy governor Ben Broadbent said on Wednesday that thepound's decline so far had been "pretty orderly, actually". Butthat was before the pound plunged 6 percent in just two minutesearly on Friday.

Volatility like that is bound to raise the ghosts of"sterling crisis" past, namely 1967, 1976 and 1992. Mostobservers say we're not there yet, but markets are nervous.

Sterling will remain extremely sensitive to statements fromPrime Minister Theresa May, her ministers and European leaderson how the Brexit process unfolds.

Lawmakers from PM May's ruling Conservative Party say thefall in sterling has made Britain more competitive, but manyfinancial market analysts say it reflects the negative view therest of the world has of Brexit Britain.

The next major step in the Brexit process will be when Maysends, by the end of March, a formal notification to the EU thatBritain is preparing to leave, invoking Article 50 of the EU'sLisbon Treaty. That starts a two-year negotiating window beforethe United Kingdom should leave.

Still, politics could intervene: the U.S. presidentialelection takes place on November 8, Italy faces a referendum onDec. 4, France holds a presidential election on April 23 and May7 and Germany holds an election in September 2017.

Just because the pound has fallen sharply in the last threemonths, there's no reason it should automatically recover. Someinvestors have even raised the idea of parity with the dollar.

STOCKS

Central to Britain's stock market direction in the comingmonths is the exchange rate. As long as the pound remains weak,equity valuations will be revised higher. If you take the viewthat sterling will remain weak, earnings will be higher.

UK stocks are trading in a binary fashion - sterling falls,stocks rise. And vice versa. There is no sign of a "buyers'strike" hitting UK stocks or bonds right now because the BoE ishappy letting the pound take the strain as it boosts exports,and helps narrow the trade and current account deficits.

The exchange rate moves also make British companies moreattractive takeover targets for foreign firms, potentiallyfuelling a mergers and acquisition wave that would boost thevalue of UK shares.

But if, in the words of BoE governor Mark Carney, a countrydepends on "the kindness of strangers", you have to be carefulabout your currency. There may come a point when foreigninvestors take fright at sterling and stop buying UK assets.

A Reuters poll of around 30 traders, fund managers andstrategists this week predicted that the FTSE 100 will loseground over the coming year.

BANK OF ENGLAND

The Bank said in August and again in September that most ofits policymakers expected to cut rates again this year if theeconomy looked on track to slow as it had forecast.

However, Prime Minister May's comments on the damagingside-effects of his ultra-low interest rates stunned investors.

The blunt words represented a clear change of tone fromDowning Street, under its new occupant, towards the Bank ofEngland and were among the most direct from a prime ministersince the BoE won operational independence in 1997.

Carney said on Thursday he agreed "with the spirit" of May'sspeech in which she signalled action by the government to fostergrowth and said the BoE's actions had helped the economy throughthe aftermath of the 2007-09 financial crisis.

Stronger than expected recent data puts Carney in a trickyposition.

While weakening the immediate case for a further rate cut -especially as soon as next month - it is less clear whether itwill alter the BoE's longer-run expectation of a slump inbusiness investment and a gentler slowdown in consumer spending.

COMPANIES

The current consensus is that British-based companies thatearn in currencies other than the pound - such as BritishAmerican Tobacco, GlaxoSmithKline Plc - shoulddo well as their revenues will be reported in pounds.

Those reliant on domestic revenues - such as retailers - areexposed should the British economy take a hit. While recent datahas shown the economy shrugged off some the shock of the Brexitvote, the Bank of England downgraded its 2017 growth forecast tojust 0.8 percent from a previous estimate of 2.3 percent. Thegrowth outlook for 2018 was cut to 1.8 percent.

Supermarkets such as no.2 player Sainsbury's have saidsterling's fall since the Brexit will not necessarily lead tohigher grocery prices, as it could be offset by lowercommodities prices and stiff competition.

Travel companies TUI Group and Thomas Cook have seen bookings from UK customers rise this summer, asBritons defied worries that the devaluation of the pound woulddeter people from going on holidays abroad.

The swings in the price of sterling may force some companiesto hedge their currency exposure while prompting demands for payrises from workers who earn in sterling but have dollar or eurocosts.

INFLATION

Economists estimate that a sustained 10 percent fall in thepound's exchange rate adds about 0.2-0.3 percentage points toinflation over the period of a couple of years.

The Bank of England forecasts inflation will rebound toaround its 2 percent target next year and then overshoot to 2.4percent in 2018 and 2019 - the biggest medium-term overshoot ithas ever forecast.

Some banks predict a bigger, but shorter-lived, spike ininflation next year as the effects of a weaker currency passthrough more quickly to the rest of the economy than the BoEexpects.

Retailers have given a mixed picture on how soon they willpass on price rises. Some, such as fashion retailer Next havesaid they plan to raise prices rather than erode margins.

But other sectors such as groceries see differentcompetitive pressures.

While the fall in sterling should make imported food moreexpensive, Britain's biggest retailer, Tesco, sees nolet up in deflation in the UK grocery market any time soon.

A survey published by the British Retail Consortium reporteda record drop in the cost of food and found little sign of pricerises on the back of sterling's fall since the Brexit vote.

M&A

The shock vote to leave the EU chilled dealmaking activityinvolving British companies to the lowest level in at least twodecades as bosses grapple with what Brexit will cost, ThomsonReuters data shows.

BRITAIN'S PLACE IN THE WORLD

The United Kingdom's gross domestic product, forecast beforethe June 23 vote to be worth about $2.8 trillion in 2016, or theworld's fifth largest, has now slipped behind France.

Its GDP is now worth about $2.32 trillion on currentexchange rates, compared with France's $2.34 trillion. Germanyis the EU's largest economy, worth about $3.5 trillion, and theworld's fourth largest economy after the United States, Chinaand Japan. (Writing by Jamie McGeever, Guy Faulconbridge, David Milliken,Sarah Young; Editing by Toby Chopra)

More News
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.